Anxiogenic effects of m-CPP in patients with panic disorder: Comparison to caffeine's anxiogenic effects
Open Access
- 15 November 1991
- journal article
- clinical trial
- Published by Elsevier BV in Biological Psychiatry
- Vol. 30 (10), 973-984
- https://doi.org/10.1016/0006-3223(91)90119-7
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Comparative Genomics of Listeria SpeciesScience, 2001
- Stress and CaffeineClinical Neuropharmacology, 1986
- L-5-Hydroxytryptophan in the treatment of anxiety disordersJournal of Affective Disorders, 1985
- Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodoneJournal of Pharmacy and Pharmacology, 1982
- (—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodoneJournal of Pharmacy and Pharmacology, 1981
- Serotonergic Stimulation of Pituitary-Adrenocortical Function in RatsNeuroendocrinology, 1981
- The effects of benzodiazepines and serotonergic manipulations on punished respondingNeuropharmacology, 1979
- Benzodiazepines: Anxiety-Reducing Activity by Reduction of Serotonin Turnover in the BrainScience, 1972
- A Rating Instrument For Anxiety DisordersPsychosomatics, 1971
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960